Tech Company Financing Transactions
Diagnostic Hybrids Funding Round
Diagnostic Hybrids, based in Athens, secured $10 million from Summit Partners.
Transaction Overview
Company Name
Announced On
8/11/2004
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Summit Partners (Lead Investor) (Harrison Miller)
Proceeds Purpose
DHI plans to fund new research and development initiatives, expand its facilities, and pursue technology and company acquisitions.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1055 East State St 100
Athens, OH 45701
USA
Athens, OH 45701
USA
Phone
Website
Email Address
Overview
Diagnostic Hybrids innovates, develops, manufactures and markets cellular and molecular diagnostic kits for various applications in detecting a wide range of respiratory diseases, herpes infections, and other high value markers of disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Scholl
Chief Financial Officer
Geoff Morgan
Chief Operating Officer
James Brown
VP - R & D
Paul Olivo
Browse more venture capital transactions:
Prev: 8/10/2004: Orchestro venture capital transaction
Next: 8/16/2004: Actiance venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs